Imidaflea 40 mg Spot-on solution for Small Cats, Small Pet Rabbits & Small Dogs

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
01-02-2022
공공 평가 보고서 공공 평가 보고서 (PAR)
26-10-2019
DSU DSU (DSU)
30-11-2022

유효 성분:

Imidacloprid

제공처:

Chanelle Pharmaceuticals Manufacturing Limited

ATC 코드:

QP53AX17

INN (International Name):

Imidacloprid

복용량:

40 mg/pipette

약제 형태:

Spot-on solution

처방전 유형:

LM: Licensed Merchant as defined in relevant national legislation

치료 영역:

imidacloprid

승인 상태:

Authorised

승인 날짜:

2019-10-25

제품 특성 요약

                                Health Products Regulatory Authority
31 January 2022
CRN00CD0F
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Imidaflea 40 mg Spot-on solution for Small Cats, Small Pet Rabbits &
Small Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.4 ml pipette contains:
​
ACTIVE SUBSTANCE:
​
​
Imidacloprid
​
40 mg
​
​
​
EXCIPIENTS:
​
​
Butylhydroxytoluene (E 321)
​
0.4 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution
A clear pale yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats, pet rabbits and dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For cats of less than 4 kg:
Prevention and treatment of flea (_Ctenocephalides felis_)
infestations.
For pet rabbits of less than 4 kg:
Treatment of flea infestations.
For dogs of less than 4 kg:
For the prevention and treatment of flea infestations and for the
treatment of biting lice (_Trichodectes canis_) on dogs.
Fleas on dogs are killed within one day following treatment.
One treatment prevents further flea infestation for four weeks on
dogs, three to four weeks on cats and up to one week on pet
rabbits.
4.3 CONTRAINDICATIONS
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use on pet rabbits of less than 10 weeks of age.
Do not treat unweaned puppies of less than 8 weeks of age.
Do not use in known cases of hypersensitivity to the active substance
or to any of the excipients.
Health Products Regulatory Authority
31 January 2022
CRN00CD0F
Page 2 of 5
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Re-infestation from emergence of new fleas in the environment may
continue to occur for six weeks or longer after treatment
is initiated. More than one treatment may therefore be required,
depending on the level of fleas in the environment. To aid
reduction in environmental challenge, the additional use of a suitable
environmental treatment against adult fleas and their
developing stages is recommended. In order to reduce further the
environ
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림